Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Surgical and Patient Reported Outcomes in Robotic Mastectomy

NCT06335550 · Changi General Hospital · Updated 28 March 2024

What is being tested
Robotic mastectomy
For
Breast Cancer
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 21 years to 70 years. About 29 people. The full rules are on the registry page.
Where
Singapore
When
Starts or started 24 Nov 2022, ends 1 March 2024. Registered 28 March 2024.
Results
None posted yet.

In the researchers' words

Conventional nipple and/or skin-sparing mastectomy (NSM/SSM) with or without immediate reconstruction is becoming one of the mainstream surgical treatment for breast cancer and risk reducing mastectomy in recent years. While this technique provides satisfactory oncologic and aesthetic outcomes, its disadvantages include skin flap and/or nipple-areolar complex (NAC) necrosis, NAC malposition/distortion as well as visible scar(s) on the breast. In terms of technical aspects, NSM/SSM has its inherent challenges in view of limited incisions and thereby difficulties in dissection. Since 2015, a number of institutions worldwide had adopted a new technique of NSM/SSM using robotic surgical system. Institutional experiences worldwide demonstrated feasibility and safety of this technique coupled with improved patients' satisfactions. To date, there is no center in Singapore or the region offering Robotic NSM/SSM (R-NSM/R-SSM). The authors believe that robotic mastectomy is a feasible and safe technique that can be utilized in our institution and it provides superior aesthetic outcomes with less morbidity and higher patient satisfaction if compared to conventional NSM/SSM. The aim of this study is to conduct a single-arm prospective pilot study to investigate the safety and feasibility as well as learning curve of R-NSM/R-SSM.
ClinicalTrials.gov, NCT06335550

Sites

  • Changi General HospitalSingapore, Singapore